Sensory assessment of Cercospora beticola sporulation for phenotyping the partial disease resistance of sugar beet genotypes von Oerke, Erich-Christian, Leucker, Marlene, Steiner, Ulrike

Volltext

Improvement of Lesion Phenotyping in Cercospora beticola-Sugar Beet Interaction by Hyperspectral Imaging von Leucker, Marlene, Mahlein, Anne-Katrin, Steiner, Ulrike, Oerke, Erich-Christian

Volltext

Hyperspectral phenotyping on the microscopic scale: towards automated characterization of plant-pathogen interactions von Kuska, Matheus, Wahabzada, Mirwaes, Leucker, Marlene, Dehne, Heinz-Wilhelm, Kersting, Kristian, Oerke, Erich-Christian, Steiner, Ulrike, Mahlein, Anne-Katrin

Volltext

Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial von Leucker, Thorsten M., Blaha, Michael J., Jones, Steven R., Vavuranakis, Michael A., Williams, Marlene S., Lai, Hong, Schindler, Thomas H., Latina, Jacqueline, Schulman, Steven P., Gerstenblith, Gary

Volltext

The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition von Vavuranakis, Michael A., Jones, Steven R., Ziogos, Efthymios, Blaha, Michael J., Williams, Marlene S., Foran, Palmer, Schindler, Thomas H., Lai, Shenghan, Schulman, Steven P., Gerstenblith, Gary, Leucker, Thorsten M.

Volltext

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition von Ziogos, Efthymios, Chelko, Stephen P, Harb, Tarek, Engel, Morgan, Vavuranakis, Michael A, Landim-Vieira, Maicon, Walsh, Elise M, Williams, Marlene S, Lai, Shenghan, Halushka, Marc K, Gerstenblith, Gary, Leucker, Thorsten M

Volltext

Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial von Leucker, Thorsten M, Osburn, William O, Reventun, Paula, Smith, Kimberley, Claggett, Brian, Kirwan, Bridget-Anne, de Brouwer, Sophie, Williams, Marlene S, Gerstenblith, Gary, Hager, David N, Streiff, Michael B, Solomon, Scott D, Lowenstein, Charles J

Volltext

Abstract 12563: The Trajectory of Platelet Factor 4 in Acute Myocardial Infarction and the Impact of PCSK9-Inhibition von Ziogos, Efthymios, Williams, Marlene S, Vavuranakis, Michael, Blaha, Michael J, Jones, Steven R, Schulman, Steven P, Lai, Shenghan, Gerstenblith, Gary, Leucker, Thorsten M

Volltext

Abstract 15287: Evolocumab Inhibits the Acute Rise in Lipoprotein(a) in Patients With Non-ST Elevation Myocardial Infarction (NSTEMI)- Results From the EVACS Study von Vavuranakis, Michael, Blaha, Michael J, Jones, Steven R, Schindler, Thomas, Williams, Marlene S, Latina, Jacqueline M, Schulman, Steven P, Gerstenblith, Gary, Leucker, Thorsten M

Volltext

Effect of Evolocumab on Atherogenic Lipoproteins during the Peri- and Early Post-Infarction Period: A Placebo Controlled, Randomized Trial von Leucker, Thorsten M., Blaha, Michael J., Jones, Steven R., Vavuranakis, Michael A., Williams, Marlene S., Lai, Hong, Schindler, Thomas H., Latina, Jacqueline, Schulman, Steven P., Gerstenblith, Gary

Volltext

Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19 von Leucker, Thorsten M., Osburn, William O., Reventun, Paula, Smith, Kimberley, Claggett, Brian, Kirwan, Bridget-Anne, de Brouwer, Sophie, Williams, Marlene S., Gerstenblith, Gary, Hager, David N., Streiff, Michael B., Solomon, Scott D., Lowenstein, Charles J.

Volltext